Aripiprazole EP Impurity E

CAS : 129722-25-4

Ref. 3D-IA171042

Informations sur le produit

• Nom: Aripiprazole EP Impurity E
• Synonymes: Dehydro Aripiprazole, 7-[4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl]Butoxy]-2(1H)-Quinolinone, 2(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-
• CAS: 129722-25-4

Description

Aripiprazole EP Impurity E is a potential impurity of aripiprazole, which is an antipsychotic drug. It has been detected as a major impurity in the drug. Aripiprazole EP Impurity E has been found to be present in human plasma and it is thought that this impurity may have pharmacological effects on humans similar to those of aripiprazole. The detection of this impurity has been achieved using LC-MS/MS methods. This method can be used for wastewater treatment due to the matrix effect of nitrogen atoms. Aripiprazole EP Impurity E may have significant implications in the diagnosis, prevention, and treatment of obesity and other metabolic disorders.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 446.37 g/mol
• Formule: C₂₃H₂₅Cl₂N₃O₂
• Degré de pureté: Min. 95%